New Adapid Primate of European Affinities from Texas (original) (raw)

Skip Nav Destination

Article navigation

Issue Cover

Research Articles| September 10 2008

John Andrew Wilson;

Department of Geological Sciences, University of Texas, Austin, Tex.; Department of Anthropology, Hunter College, City University of New York, and Department of Vertebrate Paleontology, The American Museum of Natural History, New York, N.Y.

Search for other works by this author on:

Frederick S. Szalay

Department of Geological Sciences, University of Texas, Austin, Tex.; Department of Anthropology, Hunter College, City University of New York, and Department of Vertebrate Paleontology, The American Museum of Natural History, New York, N.Y.

Search for other works by this author on:

Folia Primatol (1976) 25 (4): 294–312.

Content Tools

Abstract

The primate Margarita stevensi n. gen. and n. sp. is described from late Eocene sediments of Texas, North America. The crushed skull of the type specimen is in the size range of Lepilemur leucopus, and the most recent relative of the new form appears to be the middle Eocene European adapid Europolemur klatti from the Geiseltal localities of the DDR. There are no indications that Margarita is closely related to the notharctine adapids. The new primate suggests that the Eocene of eastern North America was the homeland of lemuriforms with close European phylogenetic affinities. The posteriorly directed foramen magnum indicates a relatively small brain size and the dentition suggests an insectivorous-carnivorous dietary regime.

This content is only available via PDF.

© 1976 S. Karger AG, Basel

1976

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.

Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

You do not currently have access to this content.

Sign in

Digital Version

Pay-Per-View Access

$39.00

1 Karger Article Bundle Token

$150

Rental

This article is also available for rental through DeepDyve.